Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Symmetric dimethylguanidino valeric acid, a novel single biomarker of hepatic steatosis.
Rodionov RN, Jarzebska N, Koay YC, Li M, Kuhn M, Bornstein SR, Martens-Lobenhoffer J, Eslam M, Chen FW, Rubets E, Markov AG, Weiss N, Birkenfeld A, Schwarz P, Bode-Böger SM, Perakakis N, O'Sullivan JF, George J. Rodionov RN, et al. Among authors: perakakis n. iScience. 2024 Nov 13;27(12):111366. doi: 10.1016/j.isci.2024.111366. eCollection 2024 Dec 20. iScience. 2024. PMID: 39660051 Free PMC article.
Efficacy of finerenone in patients with type 2 diabetes, chronic kidney disease and altered markers of liver steatosis and fibrosis: A FIDELITY subgroup analysis.
Perakakis N, Bornstein SR, Birkenfeld AL, Linkermann A, Demir M, Anker SD, Filippatos G, Pitt B, Rossing P, Ruilope LM, Kolkhof P, Lawatscheck R, Scott C, Bakris GL; FIDELIO-DKD and FIGARO-DKD investigators. Perakakis N, et al. Diabetes Obes Metab. 2024 Jan;26(1):191-200. doi: 10.1111/dom.15305. Epub 2023 Oct 10. Diabetes Obes Metab. 2024. PMID: 37814928
Sex-based differences in insulin resistance.
Gado M, Tsaousidou E, Bornstein SR, Perakakis N. Gado M, et al. Among authors: perakakis n. J Endocrinol. 2024 Feb 12;261(1):e230245. doi: 10.1530/JOE-23-0245. Print 2024 Apr 1. J Endocrinol. 2024. PMID: 38265844 Review.
Cross-Talk of NADPH Oxidases and Inflammation in Obesity.
Morawietz H, Brendel H, Diaba-Nuhoho P, Catar R, Perakakis N, Wolfrum C, Bornstein SR. Morawietz H, et al. Among authors: perakakis n. Antioxidants (Basel). 2023 Aug 9;12(8):1589. doi: 10.3390/antiox12081589. Antioxidants (Basel). 2023. PMID: 37627585 Free PMC article. Review.
Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).
Sandforth A, von Schwartzenberg RJ, Arreola EV, Hanson RL, Sancar G, Katzenstein S, Lange K, Preißl H, Dreher SI, Weigert C, Wagner R, Kantartzis K, Machann J, Schick F, Lehmann R, Peter A, Katsouli N, Ntziachristos V, Dannecker C, Fritsche L, Perakakis N, Heni M, Nawroth PP, Kopf S, Pfeiffer AFH, Kabisch S, Stumvoll M, Schwarz PEH, Hauner H, Lechner A, Seissler J, Yurchenko I, Icks A, Solimena M, Häring HU, Szendroedi J, Schürmann A, de Angelis MH, Blüher M, Roden M, Bornstein SR, Stefan N, Fritsche A, Birkenfeld AL. Sandforth A, et al. Among authors: perakakis n. Lancet Diabetes Endocrinol. 2023 Nov;11(11):798-810. doi: 10.1016/S2213-8587(23)00235-8. Epub 2023 Sep 25. Lancet Diabetes Endocrinol. 2023. PMID: 37769677 Clinical Trial.
vPIF-1 is an insulin-like antiferroptotic viral peptide.
Belavgeni A, Maremonti F, Tonnus W, Stadtmüller M, Gavali S, Mallais M, Flade K, Brucker A, Becker JN, Beer K, Tmava M, Stumpf J, Gembardt F, Hugo C, Giacca M, Hale BG, Perakakis N, Sha W, Pratt DA, Schally AV, Bornstein SR, Linkermann A. Belavgeni A, et al. Among authors: perakakis n. Proc Natl Acad Sci U S A. 2023 May 23;120(21):e2300320120. doi: 10.1073/pnas.2300320120. Epub 2023 May 15. Proc Natl Acad Sci U S A. 2023. PMID: 37186845 Free PMC article.
Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases.
Perakakis N, Harb H, Hale BG, Varga Z, Steenblock C, Kanczkowski W, Alexaki VI, Ludwig B, Mirtschink P, Solimena M, Toepfner N, Zeissig S, Gado M, Abela IA, Beuschlein F, Spinas GA, Cavelti-Weder C, Gerber PA, Huber M, Trkola A, Puhan MA, Wong WW, Linkermann A, Mohan V, Lehnert H, Nawroth P, Chavakis T, Mingrone G, Wolfrum C, Zinkernagel AS, Bornstein SR. Perakakis N, et al. Lancet Diabetes Endocrinol. 2023 Sep;11(9):675-693. doi: 10.1016/S2213-8587(23)00154-7. Epub 2023 Jul 28. Lancet Diabetes Endocrinol. 2023. PMID: 37524103 Review.
Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism.
Castells-Nobau A, Moreno-Navarrete JM, de la Vega-Correa L, Puig I, Federici M, Sun J, Burcelin R, Guzylack-Piriou L, Gourdy P, Cazals L, Arnoriaga-Rodríguez M, Frühbeck G, Seoane LM, López-Miranda J, Tinahones FJ, Dieguez C, Dumas ME, Pérez-Brocal V, Moya A, Perakakis N, Mingrone G, Bornstein S, Rodriguez Hermosa JI, Castro E, Fernández-Real JM, Mayneris-Perxachs J. Castells-Nobau A, et al. Among authors: perakakis n. Gut. 2024 Nov 7:gutjnl-2024-332602. doi: 10.1136/gutjnl-2024-332602. Online ahead of print. Gut. 2024. PMID: 39358003 Free article.
High interindividual variability in LDL-cholesterol reductions after inclisiran administration in a real-world multicenter setting in Germany.
Makhmudova U, Schatz U, Perakakis N, Kassner U, Schumann F, Axthelm C, Stürzebecher P, Sinning DL, Doevelaar A, Rohn B, Westhoff T, Vogt A, Scholl M, Kästner U, Geiling JA, Stach K, Mensch J, Lorenz E, Paitazoglou C, Eitel I, Baessler A, Steinhagen-Thiessen E, Koenig W, Schulze PC, Landmesser U, Laufs U, Weingärtner O; German Inclisiran Network (GIN). Makhmudova U, et al. Among authors: perakakis n. Clin Res Cardiol. 2023 Nov;112(11):1639-1649. doi: 10.1007/s00392-023-02247-8. Epub 2023 Jul 9. Clin Res Cardiol. 2023. PMID: 37422840 Free PMC article.
73 results